[{"words": [{"word": "业绩", "head": 2, "tag": "n", "deprels": "SBV", "no": 0}, {"word": "变动", "head": 3, "tag": "v", "deprels": "ATT", "no": 1}, {"word": "原因", "head": 4, "tag": "n", "deprels": "SBV", "no": 2}, {"word": "说明", "head": 0, "tag": "v", "deprels": "HED", "no": 3}, {"word": "1", "head": 12, "tag": "m", "deprels": "ADV", "no": 4}, {"word": "、", "head": 8, "tag": "wp", "deprels": "WP", "no": 5}, {"word": "报告期", "head": 8, "tag": "n", "deprels": "ATT", "no": 6}, {"word": "内", "head": 12, "tag": "nd", "deprels": "ADV", "no": 7}, {"word": "，", "head": 8, "tag": "wp", "deprels": "WP", "no": 8}, {"word": "公司", "head": 11, "tag": "n", "deprels": "ATT", "no": 9}, {"word": "净利润", "head": 12, "tag": "n", "deprels": "SBV", "no": 10}, {"word": "有", "head": 4, "tag": "v", "deprels": "VOB", "no": 11}, {"word": "较", "head": 14, "tag": "d", "deprels": "ADV", "no": 12}, {"word": "大", "head": 15, "tag": "a", "deprels": "ATT", "no": 13}, {"word": "幅度", "head": 16, "tag": "n", "deprels": "ADV", "no": 14}, {"word": "增长", "head": 12, "tag": "v", "deprels": "VOB", "no": 15}, {"word": "，", "head": 12, "tag": "wp", "deprels": "WP", "no": 16}, {"word": "主要", "head": 19, "tag": "b", "deprels": "ATT", "no": 17}, {"word": "原因", "head": 20, "tag": "n", "deprels": "SBV", "no": 18}, {"word": "是", "head": 24, "tag": "v", "deprels": "ATT", "no": 19}, {"word": "公司", "head": 22, "tag": "n", "deprels": "ATT", "no": 20}, {"word": "生物", "head": 20, "tag": "n", "deprels": "VOB", "no": 21}, {"word": "制药", "head": 24, "tag": "v", "deprels": "ATT", "no": 22}, {"word": "领域", "head": 25, "tag": "n", "deprels": "ATT", "no": 23}, {"word": "谷胱", "head": 26, "tag": "nh", "deprels": "SBV", "no": 24}, {"word": "甘肽", "head": 27, "tag": "v", "deprels": "ATT", "no": 25}, {"word": "产品", "head": 28, "tag": "n", "deprels": "ATT", "no": 26}, {"word": "销量", "head": 32, "tag": "n", "deprels": "SBV", "no": 27}, {"word": "较", "head": 32, "tag": "p", "deprels": "ADV", "no": 28}, {"word": "去年", "head": 31, "tag": "nt", "deprels": "ATT", "no": 29}, {"word": "同期", "head": 29, "tag": "nd", "deprels": "POB", "no": 30}, {"word": "有", "head": 12, "tag": "v", "deprels": "COO", "no": 31}, {"word": "较", "head": 34, "tag": "d", "deprels": "ADV", "no": 32}, {"word": "大", "head": 35, "tag": "a", "deprels": "ADV", "no": 33}, {"word": "增长", "head": 32, "tag": "v", "deprels": "VOB", "no": 34}, {"word": "，", "head": 32, "tag": "wp", "deprels": "WP", "no": 35}, {"word": "对", "head": 42, "tag": "p", "deprels": "ATT", "no": 36}, {"word": "公司", "head": 40, "tag": "n", "deprels": "ATT", "no": 37}, {"word": "整体", "head": 40, "tag": "n", "deprels": "ATT", "no": 38}, {"word": "利润", "head": 37, "tag": "n", "deprels": "POB", "no": 39}, {"word": "的", "head": 37, "tag": "u", "deprels": "RAD", "no": 40}, {"word": "贡献", "head": 43, "tag": "n", "deprels": "SBV", "no": 41}, {"word": "增大", "head": 32, "tag": "v", "deprels": "COO", "no": 42}], "sentence": "业绩变动原因说明1、报告期内，公司净利润有较大幅度增长，主要原因是公司生物制药领域谷胱甘肽产品销量较去年同期有较大增长，对公司整体利润的贡献增大"}]